MDxHealth SA (MDXH)
NASDAQ: MDXH · Real-Time Price · USD
0.1490
+0.0049 (3.40%)
At close: Nov 16, 2026, 4:00 PM EST
0.1400
-0.0090 (-6.04%)
Pre-market: Nov 17, 2026, 8:07 AM EST
MDxHealth Stock Forecast
MDXH's stock price has decreased by -95.91% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
According to 6 analysts polled by S&P Global, MDxHealth stock has a consensus rating of "Hold" and an average price target of $0.83. The average 1-year stock price forecast is 459.26% higher than the current stock price, while the lowest is $0.50 (+235.57%) and the highest is $1.00 (+571.14%).
Price Target: $0.83 (+459.26%)
Analyst Consensus: Hold
Price Target
ChartAnalyst Ratings
The average analyst rating for MDxHealth stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 4 | 4 | 4 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 2 | 2 | 2 | 5 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| TD Cowen | TD Cowen | Buy Maintains $0.14 → $1 | Buy | Maintains | $0.14 → $1 | +571.14% | Nov 13, 2026 |
| BTIG | BTIG | Hold Downgrades n/a | Hold | Downgrades | n/a | n/a | Oct 19, 2026 |
| Lake Street | Lake Street | Hold Downgrades $3 → $0.5 | Hold | Downgrades | $3 → $0.5 | +235.57% | Oct 16, 2026 |
| Craig-Hallum | Craig-Hallum | Hold Downgrades n/a | Hold | Downgrades | n/a | n/a | Oct 16, 2026 |
| William Blair | William Blair | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Aug 14, 2026 |
Financial Forecast
Revenue This Year
109.69M
from 107.88M
Increased by 1.69%
Revenue Next Year
121.83M
from 109.69M
Increased by 11.06%
EPS This Year
-0.46
from -0.43
EPS Next Year
-0.38
from -0.46
EPS and Forward PE are based on non-GAAP adjusted numbers.